Skip to main content
. 2023 Jun 9;31(spe2):e263313. doi: 10.1590/1413-785220233102e263313

Table 3. Descriptive analysis and comparison of comorbidities with serum albumin.

Variables/ Comorbidities Category Albumin * Low (n=20) Albumin * Normal (n=68) p-value
Number of comorbidities X±DP 1.11 ± 0.81 0.63 ± 1.08 0.00661
Diabetes        
No N (%) 13 (68.4%) 56 (87.5%) 0.07783
Yes N (%) 6 (31.6%) 8 (12.5%)  
Smoking        
No N (%) 17 (89.5%) 56 (87.5%) 1.00003
Yes N (%) 2 (10.5%) 8 (12.5%)  
Alcoholism        
No N (%) 16 (84.2%) 60 (93.8%) 0.19333
Yes N (%) 3 (15.8%) 4 (6.3%)  
Arterial hypertension        
No N (%) 9 (47.4%) 46 (71.9%) 0.04732
Yes N (%) 10 (52.6%) 18 (28.1%)  
Comorbidities        
No N (%) 5 (26.3%) 43 (67.2%) 0.00152
Yes N (%) 14 (73.7%) 21 (32.8%)  
Number of comorbidities grouped        
0 N (%) 5 (26.3%) 43 (67.2%) 0.00463
1 N (%) 7 (36.8%) 10 (15.6%)  
2-4 N (%) 7 (36.8%) 11 (17.2%)  

*Albumin. 1 Mann-Whitney test; 2 Chi-square test; 3 Fisher›s exact test.